We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANEB
5051
DELISTED
Anebulo Pharmaceuticals
ANEB
$998 ﹤0.01%
+399
New +$939
BNT
5052
Brookfield Wealth Solutions
BNT
$11.7B
$959 ﹤0.01%
21
-6,030
-100% -$267K
RPTX
5053
DELISTED
Repare Therapeutics
RPTX
$933 ﹤0.01%
530
CETX icon
5054
Cemtrex
CETX
$4.32M
$906 ﹤0.01%
+16
New +$2.58K
VATE icon
5055
INNOVATE Corp
VATE
$106M
$851 ﹤0.01%
174
+173
+17,300% +$899
KRP icon
5056
Kimbell Royalty Partners
KRP
$1.46B
$849 ﹤0.01%
63
-17,057
-100% -$240K
NRP icon
5057
Natural Resource Partners
NRP
$1.31B
$840 ﹤0.01%
8
-45
-85% -$4.58K
OST icon
5058
Ostin Technology Group
OST
$839 ﹤0.01%
495
-349
-41% -$826
CVE.WS
5059
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$815 ﹤0.01%
66
-265
-80% -$2.86K
YHGJ icon
5060
Yunhong Green CTI Ltd
YHGJ
$7.75M
$784 ﹤0.01%
+17
New +$109
LPSN icon
5061
LivePerson
LPSN
$22M
$773 ﹤0.01%
88
-115
-57% -$1.62K
XBP icon
5062
XBP Global Holdings
XBP
$40M
$762 ﹤0.01%
+94
New +$766
EBON icon
5063
Ebang International Holdings
EBON
$12.6M
$725 ﹤0.01%
161
GEG icon
5064
Great Elm Group
GEG
$68.7M
$684 ﹤0.01%
+279
New +$663
SDM
5065
DELISTED
Smart Digital Group
SDM
$649 ﹤0.01%
+351
New +$4.83K
LB
5066
LandBridge Co
LB
$2.09B
$640 ﹤0.01%
12
-3,573
-100% -$197K
ESTA icon
5067
Establishment Labs
ESTA
$2.71B
$615 ﹤0.01%
15
-4,144
-100% -$169K
SST icon
5068
System1
SST
$14.3M
$605 ﹤0.01%
86
-104
-55% -$718
IPHA
5069
Innate Pharma
IPHA
$171M
$593 ﹤0.01%
307
PIII icon
5070
P3 Health Partners
PIII
$34.9M
$590 ﹤0.01%
+66
New +$498
POET icon
5071
POET Technologies
POET
$1.1B
$587 ﹤0.01%
+106
New +$599
STEM icon
5072
Stem
STEM
$44.3M
$578 ﹤0.01%
33
-8,556
-100% -$121K
PDS
5073
Precision Drilling
PDS
$940M
$564 ﹤0.01%
10
-2,777
-100% -$152K
XBIT icon
5074
XBiotech
XBIT
$68.6M
$551 ﹤0.01%
207
+206
+20,600% +$610
PAY icon
5075
Paymentus
PAY
$4.62B
$520 ﹤0.01%
17
-11,436
-100% -$378K

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.